Skip to main content

Latest updates from major conferences

Editor(s):
Delong Liu: New York Medical College, USA
Kongming Wu: Tongji Medical College of Huazhong University of Science and Technology, China

Submission Status: Open   |   Submission Deadline: Ongoing 


 Journal of Hematology & Oncology and Experimental Hematology & Oncology are calling for submissions to our Collection on "Latest updates from major conferences." This cross-journal series intends to publish Correspondences with latest updates on novel agents and regimens from major conferences on blood and cancer disorders.

Submit to collection

Journal of Hematology & Oncology 

Experimental Hematology & Oncology 

About the collection

Journal of Hematology & Oncology and Experimental Hematology & Oncology are calling for submissions to our Collection on "Latest updates from major conferences." This cross-journal series intends to publish Correspondences with latest updates on novel agents and regimens from major conferences on blood and cancer disorders. Each Correspondence serves as a summary and analysis of 5 or more abstracts on a similar focus from a major international conference.

Each Correspondence should start with “To the editor," include two tables, and fewer than 700 words in the text. It should also have two subsections to better delineate the content. There should be fewer than 12 references. 

Image credit: © PR. H. PIGUET / CNRI /  Science Photo Library

  1. Developments in investigational agents and novel regimens in acute myeloid leukemia (AML) were reported in the 2022 American Society of Hematology (ASH) annual meeting. Encouraging efficacy data were presented...

    Authors: Katherine W. DiNardo, Thomas W. LeBlanc and Hui Chen
    Citation: Journal of Hematology & Oncology 2023 16:17

Submission Guidelines

Back to top

For both journals, the submission guidelines and links to submit are available here:

During the submission process you will be asked whether you are submitting to a Collection, please select "Latest updates from major conferences" from the dropdown menu.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.